CompletedNCT04005352
Study to Assess the Efficacy and Safety of Brolucizumab 6mg Compared to Aflibercept 2 mg in a Treat-to-control Regimen (TALON)
PHASE3 · 734 planned enrolment
- Countries listed
- 20
- Registry update
- October 9, 2024
Registry Intervention View
Brolucizumab 6 mg
Trial registrations containing the exact intervention label Brolucizumab 6 mg.
Exact registry label · Not reported
2 linked registrations
No aliases or equivalent products have been inferred.
Topics connected by trial metadata
2 linked registrations report posted results
This is a registry availability fact, not a safety result, comparison, or conclusion.
Understand the safety boundary →Registered trials
CompletedNCT03386474
Study of Safety and Efficacy of Brolucizumab 6 mg Drug Product Intended for Commercialization in Patients With nAMD
PHASE3 · 151 planned enrolment
- Countries listed
- 2
- Registry update
- January 5, 2021